Cargando…
Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103)
BACKGROUND: Cervical cancer is still present a major public health problem, especially in developing countries. In International Federation of Gynaecology and Obstetrics 2018, allowing assessment of retroperitoneal lymph nodes by imaging and/or pathological findings and, if deemed metastatic, the ca...
Autores principales: | He, Misi, Guo, Mingfang, Zhou, Qi, Tang, Ying, Zhong, Lin, Liu, Qing, Fan, Xiaomei, Zhao, Xiwa, Zhang, Xiang, Chen, Gang, Shen, Yuanming, Xu, Qin, Chen, Xiaojun, Li, Yuancheng, Zou, Dongling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157346/ https://www.ncbi.nlm.nih.gov/pubmed/36998225 http://dx.doi.org/10.3802/jgo.2023.34.e55 |
Ejemplares similares
-
Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial
por: Roy, P., et al.
Publicado: (2018) -
A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial)
por: Qiu, Junjun, et al.
Publicado: (2023) -
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment
por: Tinterri, Corrado, et al.
Publicado: (2023) -
A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone
por: Zhang, Zhan-Jie, et al.
Publicado: (2022) -
Comparative Clinical Efficacy of
‘Concurrent Chemoradiotherapy (CCRT) and Anlotinib’ Than CCRT in Patients with Locally Advanced ESCC
por: Wang, Gang, et al.
Publicado: (2022)